Shanghai, China

Dongxiao Lan

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Newron Pharmaceuticals S.p.a.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dongxiao Lan. Retrieved from https://idiyas.com/inventor/dongxiao-lan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Dongxiao Lan in Pharmaceutical Chemistry

Introduction

Dongxiao Lan is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry. His work primarily focuses on the development of novel compounds with potential therapeutic applications.

Latest Patents

Dongxiao Lan holds a patent for a process related to the production of substituted 2-[2-(phenyl)ethylamino] alkaneamide derivatives. This invention refers to a method for preparing a compound of formula (I) or a pharmaceutically acceptable salt thereof. The patent outlines various substituents and structural configurations that enhance the compound's efficacy.

Career Highlights

Dongxiao Lan is currently associated with Newron Pharmaceuticals S.p.a., where he continues to innovate in the pharmaceutical sector. His expertise in chemical processes has positioned him as a valuable asset in the development of new therapeutic agents.

Collaborations

He has collaborated with esteemed colleagues such as Sizhong Wu and William W. Leong, contributing to a dynamic research environment that fosters innovation.

Conclusion

Dongxiao Lan's work exemplifies the intersection of innovation and pharmaceutical development. His contributions are paving the way for new treatments and advancements in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…